Securing the survival of patients with cancer disease is traditionally considered the main
task of clinical oncologists. However, for many types of malignant disease, the survival rates …

Introduction: Multiple studies have demonstrated that tyrosine kinase inhibitors (TKIs) exert a
significant extent of control over chronic myeloid leukemia (CML), as evidenced by studies …

The overwhelming success of tyrosine kinase inhibitor (TKI) therapy in chronic myeloid
leukemia (CML) patients has opened a discussion among medical practitioners and the lay …

Advancements in the management of patients with chronic myeloid leukemia (CML) allowed
them to achieve survival comparable with their healthy counterparts. Consequently, their …

Résumé Le traitement de la leucémie myéloïde chronique repose sur l'utilisation
d'inhibiteurs de la tyrosine kinase BCR:: ABL1. Le bosutinib est un inhibiteur compétitif de …

Chronic myeloid leukemia (CML) has evolved from an invariably fatal disease to a chronic
disorder that can be treated with targeted drugs and allows survival expectations …

目的回顾性分析母亲患慢性粒细胞白血病(CML) 对新生儿的影响. 方法对2010 年1 月至2022
年1 月北京大学人民医院产科收治的41 例患CML 孕妇及其分娩的36 例新生儿和同期年龄匹配 …

The incidence of cancers in people younger than 50 years old continues to increase, 1 and
because of the delayed maternal age at birth, more women are faced with the unwanted …

Introduction Chronic myeloid leukemia (CML) has evolved in the past 20 years from an
invariably fatal disease to a long-lasting, chronic disorder that can be treated with different …

In considering patients with chronic myeloid leukemia (CML) of child‐bearing age, desiring
the option to plan a family, current tyrosine kinase inhibitor (TKIs) therapy options have …